SCHEMBL17258696

SCHEMBL17258696

CS(=O)(=O)N(c1ccccc1C#N)S(C)(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
HTT P42858 1/20 0.49
TSHR P16473 1/20 0.42
NR3C1 P04150 1/20 0.38
RORC P51449 1/20 0.37
POLB P06746 1/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
PTPN1 P18031 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
USP8 P40818 1/20 0.35
USP7 Q93009 1/20 0.35
PKM P14618 1/20 0.35
HSD11B1 P28845 2/20 0.34
LMNA P02545 1/20 0.34
NR1H3 Q13133 1/20 0.34
KMT2A Q03164 2/20 0.33
MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30468495 0.83 ALDH1A1 (0.51) ALDH1A1HTTTSHRNR3C1POLB
SCHEMBL1291364 0.83 ALDH1A1 (0.51) ALDH1A1HTTTSHRNR3C1POLB
SCHEMBL3061461 0.82 PTPN1 (0.36) ALDH1A1HTTPTPN1CA2KMT2A
SCHEMBL21048806 0.81 ALDH1A1 (0.46) ALDH1A1HTTTSHRNR3C1RORC
SCHEMBL21048811 0.78 CYP3A4 (0.47) ALDH1A1HTTTSHRRORCPOLB
SCHEMBL31652674 0.77 PTPN1 (0.36) ALDH1A1HTTPOLBKDM4EGAA
SCHEMBL17258804 0.77 HCRTR1 (0.40) ALDH1A1HTTPOLBMAPTKDM4E
SCHEMBL1627549 0.77 PTPN1 (0.36) ALDH1A1HTTPOLBKDM4EGAA
SCHEMBL17258750 0.76 ALDH1A1 (0.41) ALDH1A1HTTTSHRNR3C1RORC
SCHEMBL21048901 0.75 PTGS2 (0.36) ALDH1A1HTTMAPTPTPN1USP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143021-B1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER (US) 2019-06-12 EP disclosed
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2018-07-17 US disclosed
EP-3143021-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES Pfizer Inc (US) 2017-03-22 EP disclosed
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. (US) 2017-03-16 US disclosed
US-9518052-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2016-12-13 US disclosed
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. 2015-11-19 US disclosed
WO-2015173683-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. (US) 2015-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines CBR3, HRH4, REN ALDH1A1 2993/4885HTT 499/4885TSHR 330/4885
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 ALDH1A1 3745/4885HTT 373/4885TSHR 85/4885
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 ALDH1A1 3745/4885HTT 373/4885TSHR 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.